Distinguishing clinically important from unimportant prostate cancers before treatment: Value of systematic biopsies

Journal of Urology

Volumn 156, Issue 3, 1996, Pages 1059-1063

  Goto, Yasuki ^a   Ohori, Makoto ^a   Arakawa, Atushi ^a   Kattan, Michael W ^a   Wheeler, Thomas M ^a   Scardino, Peter T ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

biopsy, needle; neoplasm staging; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME;

EID: 0029737530     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65702-1     Document Type: Article

References (21)

1. Wingo, P. A., Tong, T. and Bolden, S.: Cancer statistics, 1995. CA, 45: 8, 1995.
2. Scardino, P. T., Weaver, R. and Hudson, M. A.: Early detection of prostate cancer. Hum. Path., 23: 211, 1992.
3. Epstein, J. I., Walsh, P. C., Carmichael, M. and Brendler, C. B.: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. J.A.M.A., 271: 368, 1994.
4. Ohori, M., Wheeler, T. M., Dunn, J. K., Stamey, T. A. and Scardino, P. T.: The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J. Urol., part 2, 152: 1714, 1994.
5. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy. Urol. Clin. N. Amer., 20: 713, 1993.
6. Thompson, I. M. and Zeidman, E. J.: Extended follow-up of stage A1 carcinoma of the prostate. Urology, 33: 455, 1989.
7. Stamey, T. A.: Making the most out of six systematic sextant biopsies. Urology, 45: 2, 1995.
8. Irwin, M. B. and Trapasso, J. G.: Identification of insignificant prostate cancers: analysis of preoperative parameters. Urology, 44: 862, 1994.
9. Terris, M. K., Haney, D. J., Johnstone, I. M., McNeal, J. E. and Stamey, T. A.: Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology, 45: 75, 1995.
10. Goto, Y., Ohori, M., Arakawa, A., Wheeler, T. M. and Scardino, P. T.: Distinguishing clinically important from unimportant prostate cancers before treatment: preliminary report. J. Urol., part 2, 151: 289A, abstract 248, 1994.
11. Ohori, M., Wheeler, T. M. and Scardino, P. T.: The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer, 74: 104, 1994.
12. Greene, D. R., Wheeler, T. M., Egawa, S. and Scardino, P. T.: A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J. Urol., 146: 1069, 1991.
13. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression following radical retropubic prostatectomy. Cancer, 71: 3582, 1993.
14. Paulson, D. F., Moul, J. W. and Walther, P. J.: Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J. Urol., 144: 1180, 1990.
15. Ohori, M., Scardino, P. T., Lapin, S. L., Seal-Hawkins, C., Link, J. and Wheeler, T. M.: The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Amer. J. Surg. Path., 17: 1252, 1993.
16. Trapasso, J. G., deKernion, J. B., Smith, R. B. and Dorey, F.: The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J. Urol., part 2, 152: 1821, 1994.
17. Terris, M. K., McNeal, J. E. and Stamey, T. A.: Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J. Urol., 148: 829, 1992.
18. Dugan, J. A., Bostwick, D. G., Myers, R. P., Qian, J., Bergstralh, E. J. and Oesterling, J. E.: The definition and preoperative prediction of clinically insignificant prostate cancer. J.A.M.A., 275: 288, 1996.
19. Kattan, M., Adams, D. A. and Parks, M. S.: A comparison of machine learning with human judgment. J. Manag. Inf. Sys., 9: 37, 1993.
20. Miles, B. J. and Kattan, M. W.: Computer modeling of prostate cancer treatment. A paradigm for oncologic management? Surg. Oncol. Clin. N. Amer., 4: 361, 1995.
21. Kattan, M. W., Goto, Y., Miles, B. J., Ohori, M. and Scardino, P. T.: Recursive partitioning vs. logistic regression in the prediction of clinically important prostate cancer. Med. Decis. Making, 14: 434, 1994.